RIGImmune Inc.
PrivateLast Round
Series A
Apr 1, 2024
Est. Valuation
$18.25M
Total Funding Raised
$15M
Company Overview
RIGImmune Inc. is a biopharmaceutical company developing a new class of RNA immunotherapeutics that selectively activate the innate immune sensor RIG-I to treat diseases caused by RNA viruses and to induce antitumor immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RIGImmune Inc. Comparables
Compare RIGImmune Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 77% | |
| Xanadu Bio | 77% | |
| NorthLinks Bio | 76% | |
RIGImmune Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2024 | ||||
| Grant | Dec 7, 2022 | ||||
| VC Round | Dec 7, 2022 | ||||
| VC Round | Sep 15, 2022 | ||||
| Seed | Dec 10, 2021 |
Key People
Founding team and executive leadership
RIGImmune Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rivermount Ventures | VC Round |
| Bill & Melinda Gates Foundation | VC Round, Grant |
| Yale Ventures | Seed |
| F-Prime Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 219% MoM.
- Sep 15, 2022
Round led by F-Prime Capital
RIGImmune Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RIGImmune Inc.'s valuation, stock price, and market status.